Safety and Efficacy of Efpeglenatide in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

The aim of this study was to assess the efficacy and safety of efpeglenatide in patients with type 2 diabetes (T2D). The study was reported according to the 2020 guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. Web of Science, PubMed, and Scopu...

Descripción completa

Detalles Bibliográficos
Autores principales: Escobar, Johao, Monday, Obinna, Vemoori, Yashwanth, Yadav, Indresh, Maslamani, Abdalkareem Nael Jameel, Al Kutabi, Salem, Saeed, Leena, Khan, Areeba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599090/
https://www.ncbi.nlm.nih.gov/pubmed/37885518
http://dx.doi.org/10.7759/cureus.45927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599090/
https://www.ncbi.nlm.nih.gov/pubmed/37885518
http://dx.doi.org/10.7759/cureus.45927

Ejemplares similares